Discover 511 paid clinical trials in Cedar Rapids, Iowa. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Safety, Effectiveness, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
for
Non-small Cell Lung Cancer
Location: 15 recruiting locations
Sponsor: BioNTech SE
Sex: All
Age: 18+
Code: NCT06712316
Phase2, Phase3, Recruiting
Active & Responsive
Safety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Breast Cancer, When Given in Combination With Chemotherapy
for
Locally Advanced Breast Cancer, Triple Negative Breast Cancer,
Location: 18 recruiting locations
Sponsor: BioNTech SE
Sex: All
Age: 18+
Code: NCT06449222
Phase2, Recruiting
Active & Responsive
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
for
Breast Carcinoma, Colorectal Carcinoma,
Location: 352 recruiting locations
Sponsor: Wake Forest University Health Sciences
Sex: All
Age: 18+
Code: NCT06418204
Recruiting
Active & Responsive
National Cancer Institute "Cancer Moonshot Biobank"
for
Acute Myeloid Leukemia,
Location: 113 recruiting locations
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 13+
Code: NCT04314401
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Fenofibrate for Prevention of DR Worsening
for
Diabetic Retinopathy
Location: 58 recruiting locations
Sponsor: Jaeb Center for Health Research
Sex: All
Age: 18 - 70+
Code: NCT04661358
Phase3, Recruiting
Active & Responsive
A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors
for
Cervical Cancer,
Location: 13 recruiting locations
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT04895709
Phase1, Phase2, Recruiting
Active & Responsive
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: 40 recruiting locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06136559
Phase3, Recruiting
Active & Responsive
Genetic Epidemiology of Rotator Cuff Tears: The cuffGEN Study